Cell Cycle and Apoptosis
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
In multicellular organisms, cell proliferation and death must be regulated to maintain tissue homeostasis. Many observations suggest that this regulation may be achieved, in part, by coupling the process of cell cycle progression and programmed cell death by using and controlling a shared set of factors. An argument in favor of a link between the cell cycle and apoptosis arises from the accumulated evidence that manipulation of the cell cycle may either prevent or induce an apoptotic response. This linkage has been recognized for tumor suppressor genes such as p53 and RB, the dominant oncogene, c-Myc, and several cyclin-dependent kinases (Cdks) and their regulators. These proteins that function in proliferative pathways may also act to sensitize cells to apoptosis. Indeed, unregulated cell proliferation can result in pathologic conditions including neoplasias if it is not countered by the appropriate cell death. Translating the knowledge gained by studying the connection between cell death and cell proliferation may aid in identifying novel therapies to circumvent disease progression or improve clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Programmed Cell Death in Animal Development
Jacobson, M. D., Weil, M., & Raff, M. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81873-5 · Cited by 2,698
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
Debbas, M., & White, E. (1993) · Genes & Development · doi:10.1101/gad.7.4.546 · Cited by 871
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 743
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 726
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
Cdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
Heikkila, R., Schwab, G., Wickstrom, E., Loke, S. L., Pluznik, D. H., Watt, R., & Neckers, L. M. (1987) · Nature · doi:10.1038/328445a0 · Cited by 683
Induction of Apoptosis in Uninfected Lymphocytes by HIV-1 Tat Protein
Li, C. J., Friedman, D. J., Wang, C., Metelev, V., & Pardee, A. B. (1995) · Science · doi:10.1126/science.7716549 · Cited by 580
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Wyllie, A. H. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011623 · Cited by 497
Yan, Y., Frisén, J., Lee, M. H., Massagué, J., & Barbacid, M. (1997) · Genes & Development · doi:10.1101/gad.11.8.973 · Cited by 493
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 489
Mechanism of active transcriptional repression by the retinoblastoma protein
Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., & Dean, D. C. (1995) · Nature · doi:10.1038/375812a0 · Cited by 487
Genetic determinants of p53-induced apoptosis and growth arrest.
Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · doi:10.1101/gad.10.15.1945 · Cited by 459
Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., & Ross, R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80055-6 · Cited by 441
p53 regulates a G 2 checkpoint through cyclin B1
Innocente, S. A., Abrahamson, J. L. A., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 436
Cell cycle and apoptosis: Common pathways to life and death
King, K. L., & Cidlowski, J. A. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580206 · Cited by 406
Pan, H., & Griep, A. E. (1994) · Genes & Development · doi:10.1101/gad.8.11.1285 · Cited by 404
Cdk inhibitors in development and cancer
Wade Harper, J., & Elledge, S. J. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90011-8 · Cited by 399
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
Amati, B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 385
Bcl-2 blocks p53-dependent apoptosis.
Chiou, S. K., Rao, L., & White, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2556 · Cited by 376
Cooperative tumorigenic effects of germline mutations in Rb and p53
Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., & Jacks, T. (1994) · Nature Genetics · doi:10.1038/ng0894-480 · Cited by 368
Golstein, P. (1997) · Science · doi:10.1126/science.275.5303.1081 · Cited by 347
Activation of cyclin A-dependent protein kinases during apoptosis.
Meikrantz, W., Gisselbrecht, S., Tam, S. W., & Schlegel, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3754 · Cited by 345
Evan, G. I., Brown, L., Whyte, M., & Harrington, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80066-2 · Cited by 336
Targeted disruption of p107: functional overlap between p107 and Rb.
Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E., & Jacks, T. (1996) · Genes & Development · doi:10.1101/gad.10.13.1621 · Cited by 336
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Chen, Y.-N. P., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., Adams, P. D., Bair, K. W., & Kaelin, W. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4325 · Cited by 314
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., et al. (1996) · Genes & Development · doi:10.1101/gad.10.10.1219 · Cited by 313
Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer
MacLachlan, T. K., Sang, N., & Giordano, A. (1995) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v5.i2.20 · Cited by 309
Self-citationNegative feedback regulation of wild-type p53 biosynthesis.
Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., & Deppert, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00123.x · Cited by 286
Inhibition of apoptosis by the retinoblastoma gene product.
Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., & Israel, M. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07022.x · Cited by 281
Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
Jänicke, R. U., Walker, P. A., Lin, X. Y., & Porter, A. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01089.x · Cited by 247
Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death
Sandig, V., Brand, K., Herwig, S., Lukas, J., Bartek, J., & Strauss, M. (1997) · Nature Medicine · doi:10.1038/nm0397-313 · Cited by 234
Poluha, W., Poluha, D. K., Chang, B., Crosbie, N. E., Schonhoff, C. M., Kilpatrick, D. L., & Ross, A. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1335 · Cited by 223
p27Kip1 overexpression causes apoptotic death of mammalian cells
Wang, X., Gorospe, M., Huang, Y., & Holbrook, N. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201450 · Cited by 221
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2.
Wagner, A. J., Small, M. B., & Hay, N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2432 · Cited by 218
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
PITSLRE protein kinase activity is associated with apoptosis
Lahti, J. M., Xiang, J., Heath, L. S., Campana, D., & Kidd, V. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.1 · Cited by 210
Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
Hiromura, K., Pippin, J. W., Fero, M. L., Roberts, J. M., & Shankland, S. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5461 · Cited by 210
An, B., & Dou, Q. P. (1996) · PubMed · Cited by 205
DP and E2F proteins: coordinating transcription with cell cycle progression
W.-F. Lam, E., & La Thangue, N. B. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90057-4 · Cited by 204
The Retinoblastoma Protein: More than a Tumor Suppressor
Riley, D. J., Lee, E. Y.-H. P., & Lee, W.-H. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.000245 · Cited by 202
Leonardo, A. D., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., & Wahl, G. M. (1997) · PubMed · Cited by 198
Gil-Gomez, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7209 · Cited by 184
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 162
Han, E. K.-H., Begemann, M., Sgambato, A., Soh, J. W., Doki, Y., Xing, W. Q., Liu, W., & Weinstein, I. B. (1996) · PubMed · Cited by 158
Sidle, A., Palaty, C., Dirks, P., Wiggan, O., Kiess, M., Gill, R. M., Wong, A. K., & Hamel, P. A. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609106585 · Cited by 141
Beyaert, R., Kidd, V. J., Cornelis, S., Van de Craen, M., Denecker, G., Lahti, J. M., Gururajan, R., Vandenabeele, P., & Fiers, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11694 · Cited by 140
pRb and the Cdks in apoptosis and the cell cycle
Kasten, M. M., & Giordano, A. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400323 · Cited by 140
Self-citationMcCarthy, S. A., Symonds, H., & Dyke, T. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3979 · Cited by 116
Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes
Brown, C. R., Welch, W. J., Doxsey, S., & White, E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600107 · Cited by 113
Fromm, L., Shawlot, W., Gunning, K. B., Butel, J. S., & Overbeek, P. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6743 · Cited by 109
Fan, G., Ma, X., Kren, B. J., & Steer, C. J. (1996) · PubMed · Cited by 104
Identification of the MDM2 Oncoprotein as a Substrate for CPP32-like Apoptotic Proteases
Erhardt, P., Tomaselli, K. J., & Cooper, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15049 · Cited by 100
Donato, N. J., & Perez, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5067 · Cited by 88
Lu, Y., Yamagishi, N., Yagi, T., & Takebe, H. (1998) · Oncogene · doi:10.1038/sj.onc.1201585 · Cited by 88
Regulation of CAK kinase activity by p53
Schneider, E., Montenarh, M., & Wagner, P. (1998) · Oncogene · doi:10.1038/sj.onc.1202504 · Cited by 85
Harvey, K. J., Blomquist, J. F., & Ucker, D. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2912 · Cited by 63
Cyclin D3 Sensitizes Tumor Cells to Tumor Necrosis Factor-Induced, c-Myc-Dependent Apoptosis
Jänicke, R. U., Lin, X. Y., Lee, F. H. H., & Porter, A. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5245 · Cited by 58
Wang, J. M., Chertov, O., Proost, P., Li, J. J., Menton, P., Xu, L., Sozzani, S., Mantovani, A., Gong, W., Schirrmacher, V., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980316)75:6<925::aid-ijc16>3.0.co;2-1 · Cited by 56
Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest
Loubat, A., Rochet, N., Turchi, L., Rezzonico, R., Far, D. F., Auberger, P., Rossi, B., & Ponzio, G. (1999) · Oncogene · doi:10.1038/sj.onc.1202668 · Cited by 49
Cited by
Fu, L., Pelicano, H., Liu, J., Huang, P., & Lee, C. C. (2002) · Cell · doi:10.1016/s0092-8674(02)00961-3 · Cited by 1,270
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
Vermeulen, K., Berneman, Z. N., & Van Bockstaele, D. R. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00267.x · Cited by 461
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Al Moustafa, A.-E., & Malki, M. I. (2020) · Cancers · doi:10.3390/cancers12041050 · Cited by 362
Gupta, S., Afaq, F., & Mukhtar, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205474 · Cited by 295
Metadata
- Authors
- Pucci, B., Kasten, M., & Giordano, A.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 2
- Issue
- 4
- Pages
- 291-299
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W1966203663
- Cited by
- 652
- References
- 70
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.